Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has earned a consensus recommendation of "Hold" from the five ratings firms that are currently covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the compan